Results 21 to 30 of about 15,615 (287)

Uncomplicated percutaneous IVC filter removal following implantation time of 6033 days

Radiology Case Reports, 2020
Most patients have a time limited indication for inferior vena cava filtration. When the indication has expired, a retrievable inferior vena cava filter should be removed percutaneously, unless the risks of retrieval outweigh the benefits.
Hans Michell, MD, Gregory P. Johnston, MD, Christopher S. Morris, MD   +2 more
doaj   +1 more source

Study of helical flow inducers with different thread pitches and diameters in vena cava. [PDF]

PLoS ONE, 2018
Pulmonary embolism is a severe, potentially life-threatening condition. Inferior vena cava filters have been used to prevent recurrent pulmonary embolisms.
Ying Chen, Xiaoyan Deng, Xinying Shan, Yubin Xing   +3 more
doaj   +1 more source

Infected aortic pseudoaneurysm caused by an inferior vena cava filter

Acute Medicine & Surgery, 2022
Background Inferior vena cava filters are widely used to prevent pulmonary embolism, but they can cause serious complications. Case Presentation A 45‐year‐old man with multiple abscesses was transferred to the emergency department from another hospital ...
Hiroaki Fukasawa, Akiko Kameyama, Megumi Tsukada, Hiroshi Imamura   +3 more
doaj   +1 more source

Vena cava filters and inferior vena cava thrombosis [PDF]

Journal of Vascular Surgery, 2007
Retrievable vena cava filters (R-VCF) are a recent addition to the therapeutic armamentarium for the prevention of pulmonary embolism. However, unlike permanent vena cava filters (P-VCF), outcomes data are limited regarding complication rates.This was a retrospective comparative analysis of consecutive patients undergoing placement of R-VCF vs P-VCF at
Matthew A, Corriere, Kenneth J, Sauve, Kenneth J, Suave, Juan, Ayerdi, Brandon L, Craven, Jeanette M, Stafford, Randolph L, Geary, Matthew S, Edwards   +7 more
openaire   +2 more sources

Inferior Vena Cava Filters [PDF]

World Journal of Surgery, 2006
Venous thromboembolism (VTE) remains a common disease with significant clinical impact upon our patients. Diagnostic challenges occur because of the nonspecific nature of the presenting symptoms. The advent of multidetector computed tomography, methods to stratify patients into VTE risks (low, intermediate, high) along with serological assays (D-dimers)
openaire   +4 more sources

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

Hepatology, EarlyView., 2022
Hepatic endothelial Alk1 signaling protects from development of vascular malformations while maintaining organ‐specific endothelial differentiation and angiocrine portmanteau of the names Wingless and Int‐1 signaling. Abstract Background and Aims In hereditary hemorrhagic telangiectasia (HHT), severe liver vascular malformations are associated with ...
Christian David Schmid, Victor Olsavszky, Manuel Reinhart, Vanessa Weyer, Felix A. Trogisch, Carsten Sticht, Manuel Winkler, Sina W. Kürschner, Johannes Hoffmann, Roxana Ola, Theresa Staniczek, Joerg Heineke, Beate K. Straub, Jens Mittler, Kai Schledzewski, Peter ten Dijke, Karsten Richter, Steven Dooley, Cyrill Géraud, Sergij Goerdt, Philipp‐Sebastian Koch   +20 more
wiley   +1 more source

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis

Hepatology, EarlyView., 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Abstract Background and Aims Nucleotide‐binding oligomerization domain‐like receptor‐family pyrin domain‐containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis.
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree   +19 more
wiley   +1 more source

Emergence of highly profibrotic and proinflammatory Lrat+Fbln2+ HSC subpopulation in alcoholic hepatitis

Hepatology, EarlyView., 2022
Lrat+ quiescent hepatic stellate cells (qHSC) give rise to Lrat+Fbln2+ activated HSC (aHSC) in alcohol‐associated hepatitis and this subpopulation is highly profibrotic, inflammatory, and immunoregulatory based on their single cell transcriptomic profile. Abstract Background and Aims Relative roles of HSCs and portal fibroblasts in alcoholic hepatitis (
Steven Balog, Reika Fujiwara, Stephanie Q. Pan, Khairat B. El‐Baradie, Hye Yeon Choi, Sonal Sinha, Qihong Yang, Kinji Asahina, Yibu Chen, Meng Li, Matthew Salomon, Stanley W.‐K. Ng, Hidekazu Tsukamoto   +12 more
wiley   +1 more source

The Clinical Rationale for the Sentry Bioconvertible Inferior Vena Cava Filter for the Prevention of Pulmonary Embolism [PDF]

, 2019
The Sentry inferior vena cava (IVC) filter is designed to provide temporary protection against pulmonary embolism (PE) during transient high-risk periods and then to bioconvert after 60 days after implantation.
Ansel, Gary M., Dake, Michael D., Johnson, Matthew S., Mendes, Robert, Smouse, H. Bob   +4 more
core   +1 more source

Inferior vena cava filters

Canadian Medical Association Journal, 2015
Under fluoroscopic guidance, IVC filters are placed percutaneously via the jugular or femoral vein. Current guidelines recommend use in patients with known venous thromboembolism who have an absolute contraindication to anticoagulant therapy (e.g., patients with hemorrhagic stroke or ...
Sean A, Kennedy, Mark O, Baerlocher
openaire   +2 more sources